MAP3K2 and chronic myelogenous leukemia, BCR-ABL1 positive: Thus, ERK5 activation through WNK1 and MAP3K2 promoted prostate tumour growth and metastasis43 as well as proliferation of human chronic myeloid leukaemia cells.44